Chronic Kidney Disease - Another Step Forward

被引:48
作者
August, Phyllis [1 ,2 ,3 ]
机构
[1] New York Presbyterian Hosp, Div Nephrol & Hypertens, Dept Med, New York, NY 10032 USA
[2] New York Presbyterian Hosp, Weill Cornell Med, Dept Transplantat Med, New York, NY 10032 USA
[3] New York Presbyterian Hosp, Theresa Lang Ctr Res & Educ, New York, NY 10032 USA
关键词
CONVERTING ENZYME-INHIBITORS; PROGRESSION;
D O I
10.1056/NEJMe2215286
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:179 / 180
页数:2
相关论文
共 9 条
[1]   Dapagliflozin in Patients with Chronic Kidney Disease [J].
Heerspink, Hiddo J. L. ;
Stefansson, Bergur V. ;
Correa-Rotter, Ricardo ;
Chertow, Glenn M. ;
Greene, Tom ;
Hou, Fan-Fan ;
Mann, Johannes F. E. ;
McMurray, John J. V. ;
Lindberg, Magnus ;
Rossing, Peter ;
Sjostrom, C. David ;
Toto, Roberto D. ;
Langkilde, Anna-Maria ;
Wheeler, David C. .
NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (15) :1436-1446
[2]   Empagliflozin in Patients with Chronic Kidney Disease [J].
Herrington, William G. ;
Staplin, Natalie ;
Wanner, Christoph ;
Green, Jennifer B. ;
Hauske, Sibylle J. ;
Emberson, Jonathan R. ;
Preiss, David ;
Judge, Parminder ;
Mayne, Kaitlin J. ;
Ng, Sarah Y. A. ;
Sammons, Emily ;
Zhu, Doreen ;
Hill, Michael ;
Stevens, Will ;
Wallendszus, Karl ;
Brenner, Susanne ;
Cheung, Alfred K. ;
Liu, Zhi-Hong ;
Li, Jing ;
Hooi, Lai Seong ;
Liu, Wen ;
Kadowaki, Takashi ;
Nangaku, Masaomi ;
Levin, Adeera ;
Cherney, David ;
Maggioni, Aldo P. ;
Pontremoli, Roberto ;
Deo, Rajat ;
Goto, Shinya ;
Rossello, Xavier ;
Tuttle, Katherine R. ;
Steubl, Dominik ;
Petrini, Michaela ;
Massey, Dan ;
Eilbracht, Jens ;
Brueckmann, Martina ;
Landray, Martin J. ;
Baigent, Colin ;
Haynes, Richard .
NEW ENGLAND JOURNAL OF MEDICINE, 2023, 388 (02) :117-127
[3]   Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease - A meta-analysis of patient-level data [J].
Jafar, TH ;
Schmid, CH ;
Landa, M ;
Giatras, I ;
Toto, R ;
Remuzzi, G ;
Maschio, G ;
Brenner, BM ;
Kamper, A ;
Zucchelli, P ;
Becker, G ;
Himmelmann, A ;
Bannister, K ;
Landais, P ;
Shahinfar, S ;
de Jong, PE ;
de Zeeuw, D ;
Lau, J ;
Levey, AS .
ANNALS OF INTERNAL MEDICINE, 2001, 135 (02) :73-87
[4]   Progression risk, urinary protein excretion, and treatment effects of angiotensin-converting enzyme inhibitors in nondiabetic kidney disease [J].
Kent, David M. ;
Jafar, Tazeen H. ;
Hayward, Rodney A. ;
Tighiouart, Hocine ;
Landa, Marcia ;
de Jong, Paul ;
de Zeeuw, Dick ;
Remuzzi, Giuseppe ;
Kamper, Anne-Lise ;
Levey, Andrew S. .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2007, 18 (06) :1959-1965
[5]   Epidemiology of chronic kidney disease: an update 2022 [J].
Kovesdy, Csaba P. .
KIDNEY INTERNATIONAL SUPPLEMENTS, 2022, 12 (01) :7-11
[6]   Summary of KDIGO 2012 CKD Guideline: behind the scenes, need for guidance, and a framework for moving forward [J].
Levin, Adeera ;
Stevens, Paul E. .
KIDNEY INTERNATIONAL, 2014, 85 (01) :49-61
[7]   Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes [J].
Neal, Bruce ;
Perkovic, Vlado ;
Mahaffey, Kenneth W. ;
de Zeeuw, Dick ;
Fulcher, Greg ;
Erondu, Ngozi ;
Shaw, Wayne ;
Law, Gordon ;
Desai, Mehul ;
Matthews, David R. .
NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (07) :644-657
[8]   Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy [J].
Perkovic, V. ;
Jardine, M. J. ;
Neal, B. ;
Bompoint, S. ;
Heerspink, H. J. L. ;
Charytan, D. M. ;
Edwards, R. ;
Agarwal, R. ;
Bakris, G. ;
Bull, S. ;
Cannon, C. P. ;
Capuano, G. ;
Chu, P. -L. ;
De Zeeuw, D. ;
Greene, T. ;
Levin, A. ;
Pollock, C. ;
Wheeler, D. C. ;
Yavin, Y. ;
Zhang, H. ;
Zinman, B. ;
Meininger, G. ;
Brenner, B. M. ;
Mahaffey, K. W. ;
McGuire, Darren K. ;
Holman, Rury ;
Home, Philip ;
Scharfstein, Dan ;
Parfrey, Patrick ;
Shahinfar, Shahnaz ;
August, Phyllis ;
Chang, Tara ;
Sinha, Arjun D. ;
Januzzi, James ;
Kolansky, Daniel ;
Amerena, John ;
Hillis, Graham ;
Gorelick, Philip ;
Kissela, Brett ;
Kasner, Scott ;
Lindley, Richard ;
Fulcher, Greg ;
Ounadjela, Souhila ;
Hufert, Karina ;
von Ingersleben, Gabriele ;
Gaglia, Jason ;
Harris, Ronald ;
Hudson, Margo ;
Turchin, Alexander ;
Cheifetz, Adam .
NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (24) :2295-2306
[9]   Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes [J].
Fischereder, Michael ;
Schoenermarck, Ulf .
NEW ENGLAND JOURNAL OF MEDICINE, 2016, 374 (11) :1092-1093